ScienceDex / Researcher record
Klaus Van Leyen
- Massachusetts General Hospital · Radiology (investigator's affiliation)
- Loxagen Inc. (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Program Leader
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $312,234 | 1 | #40,479 |
| 2025 | $342,612 | 2 | #40,022 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY2025 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7847050Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Klaus Van Leyen as a PI. Multi-PI records show the full award amount for context.
- 7U01NS132332-04U01Contact PITesting the Lipoxygenase Inhibitor BPN - 27332 as acute phase stroke treatment in the SPAN network$225.7Kaward amount
- 5U01NS132332-03U01Contact PITesting the Lipoxygenase Inhibitor BPN-27332 as Acute Phase Stroke Treatment in the SPAN NetworkMassachusetts General Hospital · Radiology (investigator's affiliation)$116.9Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Klaus Van Leyen as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLoxagen Inc.
- 2025$500K Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions